Trans Chromosomics Overview
- Year Founded
-
2014

- Status
-
Private
- Employees
-
18

- Latest Deal Type
-
Corporate
- Financing Rounds
-
1
Trans Chromosomics General Information
Description
Provider of medical research and development services of pharmaceutical products. The company's services include researching on antibody drug seeds, drug development and toxicity, chromosome analysis, cell production and pharmaceutical seeds using chromosome engineering technology,
Contact Information
Website
www.trans-chromo.comCorporate Office
- 3F Odenmacho Ichiban Building
- 2-1 Nihonbashi Odenmacho, Chuo-ku
- Tokyo, 103-0011
- Japan
Corporate Office
- 3F Odenmacho Ichiban Building
- 2-1 Nihonbashi Odenmacho, Chuo-ku
- Tokyo, 103-0011
- Japan
Trans Chromosomics Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Trans Chromosomics Signals
Trans Chromosomics FAQs
-
When was Trans Chromosomics founded?
Trans Chromosomics was founded in 2014.
-
Where is Trans Chromosomics headquartered?
Trans Chromosomics is headquartered in Tokyo, Japan.
-
What is the size of Trans Chromosomics?
Trans Chromosomics has 18 total employees.
-
What industry is Trans Chromosomics in?
Trans Chromosomics’s primary industry is Drug Discovery.
-
Is Trans Chromosomics a private or public company?
Trans Chromosomics is a Private company.
-
What is Trans Chromosomics’s current revenue?
The current revenue for Trans Chromosomics is
. -
How much funding has Trans Chromosomics raised over time?
Trans Chromosomics has raised $1.32M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »